Resolution of status epilepticus after ketamine administration
Colleen Elizabeth Howing1, Farzad Razi2, Wael Hakmeh1
1Department of Emergency Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, 1000 Oakland Drive, Kalamazoo, MI 49008, United States of America.
Insights
Ketamine may help refractory status epilepticus in children. This NMDA receptor antagonist offers a potential new treatment option when standard therapies fail, warranting further investigation.
Area of Science:
- Pediatric Neurology
- Emergency Medicine
- Pharmacology
Background:
- Status epilepticus is a critical pediatric neurological emergency.
- Current treatment algorithms involve benzodiazepines, Levetiracetam, Valproic Acid, Fosphenytoin, and high-dose Propofol.
- Refractory cases often require advanced airway management and sedation.
Observation:
- A 9-month-old girl presented with a 45-minute refractory generalized seizure.
- Multiple first- and second-line antiepileptic drugs were administered without success.
- Ketamine was administered due to its NMDA receptor antagonist properties.
Findings:
- Ketamine administration resulted in the cessation of seizure activity.
- Electroencephalogram (EEG) confirmed no ongoing seizure pattern post-treatment.
- The patient recovered to baseline within one week.
Implications:
- Ketamine may serve as a third or fourth-line agent for refractory status epilepticus in children.
- Its NMDA receptor blockade mechanism presents a novel therapeutic approach.
- Emergency physicians should consider ketamine in intubation protocols and refractory seizure management.
Background:
Status Epilepticus is the most common non-traumatic neurologic emergency in childhood. Current algorithms prioritize the use of benzodiazepines as first line treatment followed by Levetiracetam or Valproic Acid, possibly Fosphenytoin and eventually high dose Propofol and intubation.
Case Report:
A 9-month old girl was brought to the emergency department with a continuous seizure involving the right upper and lower extremity for 45 min prior to arrival. Patient received a dose of rectal Diazepam, intramuscular Midazolam, 2 doses of Lorazepam, Levetiracetam, Fosphenytoin and 2 additional doses of Lorazepam. The seizure remained refractory and generalized. In anticipation of intubation, and because of its action on the NMDA receptor, Ketamine (1 mg/kg IV) was administered. The clonic movements and eye deviations stopped. Patient was intubated for airway protection, sedated with Propofol, then admitted to the PICU. EEG showed no evidence of a seizure pattern. Labs (CBC, CMP, COVID) were unremarkable except for WBC 24.5, blood glucose of 346 and CO2 of 17 with normal anion gap. Urinalysis showed a urinary tract infection. Patient was at her baseline on 1 week post-discharge re-evaluation. Ketamine theoretically may abort seizures through blockade of NMDA receptors which are unregulated in status epilepticus. To date, no randomized controlled trials have been reported. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Ketamine may have a role in treating status epilepticus. It may be considered for induction for rapid sequence intubation and possibly as a third or fourth line agent in refractory cases.
Related Concept Videos
Parenteral Anesthetics: Overview
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Depolarizing Blockers: Pharmocokinetics


